Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients-MedSci.cn

Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients

Kitadate, A; Kobayashi, H; Abe, Y; Narita, K; Miura, D; Takeuchi, M; Matsue, K

Kitadate, A (corresponding author), Kameda Med Ctr, Dept Med, Div Hematol Oncol, Kamogawa, Japan.

HAEMATOLOGICA, 2020; 105 (1): E37